Home Biotechnology Cell Cryopreservation Equipment Market Size, Top Share, Demand | Industry Report, 2034

Cell Cryopreservation Equipment Market Size, Share & Trends Analysis Report By Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks), By Application (Stem Cells, Reproductive Cells, Bioproduction Cell Lines, Primary Cells, Others), By End-use (Biopharmaceutical & Pharmaceutical Companies, Academic and Research Institutes, Biobanks, IVF Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRBI57962DR
Last Updated: Dec, 2025
Pages: 110
Author: Debashree Bora
Format: PDF, Excel

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Cell Cryopreservation Equipment Market Introduction
    2. By Equipment
      1. Introduction
        1. Equipment By Value
      2. Freezers
        1. By Value
      3. Incubators
        1. By Value
      4. Liquid Nitrogen Supply Tanks
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Stem Cells
        1. By Value
      3. Reproductive Cells
        1. By Value
      4. Bioproduction Cell Lines
        1. By Value
      5. Primary Cells
        1. By Value
      6. Others
        1. By Value
    4. By End-use
      1. Introduction
        1. End-use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Biobanks
        1. By Value
      5. IVF Clinics
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Equipment
      1. Introduction
        1. Equipment By Value
      2. Freezers
        1. By Value
      3. Incubators
        1. By Value
      4. Liquid Nitrogen Supply Tanks
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Stem Cells
        1. By Value
      3. Reproductive Cells
        1. By Value
      4. Bioproduction Cell Lines
        1. By Value
      5. Primary Cells
        1. By Value
      6. Others
        1. By Value
    4. By End-use
      1. Introduction
        1. End-use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Biobanks
        1. By Value
      5. IVF Clinics
        1. By Value
      6. Others
        1. By Value
    5. U.S.
      1. By Equipment
        1. Introduction
          1. Equipment By Value
        2. Freezers
          1. By Value
        3. Incubators
          1. By Value
        4. Liquid Nitrogen Supply Tanks
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Stem Cells
          1. By Value
        3. Reproductive Cells
          1. By Value
        4. Bioproduction Cell Lines
          1. By Value
        5. Primary Cells
          1. By Value
        6. Others
          1. By Value
      3. By End-use
        1. Introduction
          1. End-use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Biobanks
          1. By Value
        5. IVF Clinics
          1. By Value
        6. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Equipment
      1. Introduction
        1. Equipment By Value
      2. Freezers
        1. By Value
      3. Incubators
        1. By Value
      4. Liquid Nitrogen Supply Tanks
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Stem Cells
        1. By Value
      3. Reproductive Cells
        1. By Value
      4. Bioproduction Cell Lines
        1. By Value
      5. Primary Cells
        1. By Value
      6. Others
        1. By Value
    4. By End-use
      1. Introduction
        1. End-use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Biobanks
        1. By Value
      5. IVF Clinics
        1. By Value
      6. Others
        1. By Value
    5. U.K.
      1. By Equipment
        1. Introduction
          1. Equipment By Value
        2. Freezers
          1. By Value
        3. Incubators
          1. By Value
        4. Liquid Nitrogen Supply Tanks
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Stem Cells
          1. By Value
        3. Reproductive Cells
          1. By Value
        4. Bioproduction Cell Lines
          1. By Value
        5. Primary Cells
          1. By Value
        6. Others
          1. By Value
      3. By End-use
        1. Introduction
          1. End-use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Biobanks
          1. By Value
        5. IVF Clinics
          1. By Value
        6. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Equipment
      1. Introduction
        1. Equipment By Value
      2. Freezers
        1. By Value
      3. Incubators
        1. By Value
      4. Liquid Nitrogen Supply Tanks
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Stem Cells
        1. By Value
      3. Reproductive Cells
        1. By Value
      4. Bioproduction Cell Lines
        1. By Value
      5. Primary Cells
        1. By Value
      6. Others
        1. By Value
    4. By End-use
      1. Introduction
        1. End-use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Biobanks
        1. By Value
      5. IVF Clinics
        1. By Value
      6. Others
        1. By Value
    5. China
      1. By Equipment
        1. Introduction
          1. Equipment By Value
        2. Freezers
          1. By Value
        3. Incubators
          1. By Value
        4. Liquid Nitrogen Supply Tanks
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Stem Cells
          1. By Value
        3. Reproductive Cells
          1. By Value
        4. Bioproduction Cell Lines
          1. By Value
        5. Primary Cells
          1. By Value
        6. Others
          1. By Value
      3. By End-use
        1. Introduction
          1. End-use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Biobanks
          1. By Value
        5. IVF Clinics
          1. By Value
        6. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Equipment
      1. Introduction
        1. Equipment By Value
      2. Freezers
        1. By Value
      3. Incubators
        1. By Value
      4. Liquid Nitrogen Supply Tanks
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Stem Cells
        1. By Value
      3. Reproductive Cells
        1. By Value
      4. Bioproduction Cell Lines
        1. By Value
      5. Primary Cells
        1. By Value
      6. Others
        1. By Value
    4. By End-use
      1. Introduction
        1. End-use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Biobanks
        1. By Value
      5. IVF Clinics
        1. By Value
      6. Others
        1. By Value
    5. UAE
      1. By Equipment
        1. Introduction
          1. Equipment By Value
        2. Freezers
          1. By Value
        3. Incubators
          1. By Value
        4. Liquid Nitrogen Supply Tanks
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Stem Cells
          1. By Value
        3. Reproductive Cells
          1. By Value
        4. Bioproduction Cell Lines
          1. By Value
        5. Primary Cells
          1. By Value
        6. Others
          1. By Value
      3. By End-use
        1. Introduction
          1. End-use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Biobanks
          1. By Value
        5. IVF Clinics
          1. By Value
        6. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Equipment
      1. Introduction
        1. Equipment By Value
      2. Freezers
        1. By Value
      3. Incubators
        1. By Value
      4. Liquid Nitrogen Supply Tanks
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Stem Cells
        1. By Value
      3. Reproductive Cells
        1. By Value
      4. Bioproduction Cell Lines
        1. By Value
      5. Primary Cells
        1. By Value
      6. Others
        1. By Value
    4. By End-use
      1. Introduction
        1. End-use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Biobanks
        1. By Value
      5. IVF Clinics
        1. By Value
      6. Others
        1. By Value
    5. Brazil
      1. By Equipment
        1. Introduction
          1. Equipment By Value
        2. Freezers
          1. By Value
        3. Incubators
          1. By Value
        4. Liquid Nitrogen Supply Tanks
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Stem Cells
          1. By Value
        3. Reproductive Cells
          1. By Value
        4. Bioproduction Cell Lines
          1. By Value
        5. Primary Cells
          1. By Value
        6. Others
          1. By Value
      3. By End-use
        1. Introduction
          1. End-use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Biobanks
          1. By Value
        5. IVF Clinics
          1. By Value
        6. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Cell Cryopreservation Equipment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Chart Industries, Inc.
    3. PHC Holdings Corporation
    4. Eppendorf SE
    5. Merck KGaA
    6. Panasonic Corporation
    7. Azenta, Inc.
    8. Cryoport, Inc.
    9. BioLife Solutions, Inc.
    10. Taylor-Wharton Cryogenics, LLC
    11. Worthington Industries, Inc.
    12. Helmer Scientific Inc.
    13. VWR International, LLC
    14. Haier Biomedical
    15. Linde plc
    16. Air Liquide S.A.
    17. ThermoGenesis Holdings, Inc.
    18. Others
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

WhatsApp
Chat with us on WhatsApp